Workflow
中国三江化工(02198) - 2020 - 中期财报
CHINA SANJIANGCHINA SANJIANG(HK:02198)2020-09-09 08:35

Financial Performance - The overall revenue for the first half of 2020 decreased by approximately 9.8% compared to the same period in 2019, primarily due to the impact of the COVID-19 pandemic[6]. - Total revenue for the six months ended June 30, 2020, was RMB 3,778,300, a decrease of 9.8% compared to RMB 4,190,077 for the same period in 2019[30]. - Revenue from ethylene oxide reached RMB 1,208.1 million, a 14.5% increase compared to RMB 1,054.98 million in the same period of 2019[17]. - Glycol revenue decreased by 22.2% to RMB 404.7 million, primarily due to a 15.0% drop in average selling price[18]. - Polypropylene revenue fell by 20.4%, driven by a 18.4% decline in average selling price[19]. - The group reported a net foreign exchange loss of RMB 10,027,000, down from RMB 16,285,000 in the previous year, indicating an improvement[60]. - The group reported a significant increase in other income and gains to RMB 196,919, compared to RMB 98,447 in the previous year[30]. - The company's net profit attributable to shareholders for the same period was RMB 24.6 million, compared to a loss of RMB 9.8 million in the previous year, indicating a significant turnaround[38]. - The total comprehensive income for the period was RMB 4,182.2 million, up from RMB 3,594.4 million in the prior year, reflecting an increase of about 16.3%[38]. Profitability and Margins - The gross profit margin for the methanol-to-olefins production facility increased significantly to 9.2%, compared to a gross loss margin of -1.9% in the same period of 2019[9]. - The gross profit margin for the polypropylene business line increased by approximately 14.2% to about 18.1% during the review period[9]. - Overall gross margin increased by 11.8%, attributed to lower methanol prices and smaller declines in average selling prices of key products[20]. - Gross profit increased significantly to RMB 632,603, compared to RMB 206,338 in the previous year, reflecting a gross margin improvement[30]. Costs and Expenses - The cost of goods sold decreased to RMB 3,125,302,000 for the six months ended June 30, 2020, down from RMB 3,964,635,000 in 2019, reflecting a reduction of about 21%[64]. - The total tax expense for the period was RMB 79,048,000, compared to RMB 40,347,000 in the previous year, indicating an increase of approximately 96%[66]. - The actual corporate income tax rate was 17.2%, lower than the normal range of 19% to 20%, due to tax incentives related to RMB 18.6 million in R&D expenses[21]. Dividends and Shareholder Returns - The company proposed an interim dividend of RMB 0.125 per share, with a payout ratio of approximately 35.8% based on the profit attributable to shareholders[6]. - The company declared an interim dividend of HKD 0.125 per share for the six months ended June 30, 2020, compared to HKD 0.050 per share in 2019, marking a 150% increase[74]. - The company declared an interim dividend of RMB 133,594 for the period, compared to RMB 53,254 in the previous year[30]. Production and Capacity - The company maintained a relatively high overall capacity utilization rate during the review period, attributed to strict health and safety measures implemented in response to the pandemic[8]. - Ethylene oxide production volume increased by 28.4% due to full capacity operation of the new production facility[17]. - Glycol production volume decreased by 8.5% as the company focused on producing more ethylene oxide[18]. - The company maintained a stable production capacity for key products, including ethylene oxide and glycol, which are essential for various chemical applications[40]. Market and Strategic Positioning - The company’s strategy of becoming a diversified vertically integrated chemical group has proven successful, positioning it ahead of other chemical companies in the industry[10]. - The demand for ethylene oxide remained strong, driven by its role as a core component in the production of disinfectant products[10]. - The company is focused on expanding its market presence in China, particularly in the production and supply of specialty chemicals, which are in high demand[40]. - The company plans to invest in new technologies and product development to enhance its competitive edge in the chemical industry[40]. - The company is exploring potential mergers and acquisitions to further strengthen its market position and expand its product offerings[40]. - The company has set a performance guidance for the next quarter, expecting continued revenue growth driven by increased production and sales volume[40]. Financial Position and Liquidity - Total assets as of June 30, 2020, amounted to RMB 11,752,072, an increase from RMB 10,374,160 as of December 31, 2019[27]. - Current liabilities totaled RMB 7,313,735, up from RMB 6,327,256 at the end of 2019, indicating increased short-term obligations[27]. - The group has sufficient liquidity with net current liabilities of approximately RMB 1,283,960,000 as of June 30, 2020, ensuring it can meet its financial obligations[43]. - The company's cash and cash equivalents as of June 30, 2020, totaled RMB 532,849,000, a decrease from RMB 591,671,000 at the end of 2019, reflecting a decline of about 10%[82]. Debt and Financing - The total interest-bearing bank and other borrowings increased from RMB 4,095,668,000 as of December 31, 2019, to RMB 6,567,479,000 as of June 30, 2020, marking an increase of about 60.5%[89]. - The company has secured bank loans totaling RMB 3,160,000,000 for the construction of additional ethylene oxide/ethylene glycol production facilities, with RMB 1,152,000,000 utilized by June 30, 2020[90]. - The company's debt-to-asset ratio increased to 51.5% as of June 30, 2020, compared to 39.5% as of December 31, 2019, indicating a significant rise in leverage[112]. Employee and Governance - The company employed a total of 980 full-time employees as of June 30, 2020, with a comprehensive employee benefits package including housing subsidies and performance bonuses[111]. - The company’s board consists of four executive directors and three independent non-executive directors, ensuring a diverse governance structure[108]. - The company’s major shareholders include Vistra Trust (Singapore) Pte. Ltd., holding 506,451,000 shares, which accounts for approximately 42.56% of the issued share capital[105]. Inventory and Receivables - The total inventory as of June 30, 2020, was RMB 1,046,705,000, an increase from RMB 878,674,000 at the end of 2019, indicating a growth of approximately 19%[77]. - Accounts receivable decreased to RMB 445,759,000 as of June 30, 2020, from RMB 565,834,000 at the end of 2019, representing a decline of about 21%[78]. - Inventory turnover days remained stable at 55.9 days as of June 30, 2020, compared to 45.7 days as of December 31, 2019[113]. - Accounts receivable turnover days were at a low level of 24.3 days as of June 30, 2020, compared to 21.6 days as of December 31, 2019[113]. Related Party Transactions - The company’s related party payables decreased from RMB 351.8 million as of December 31, 2019, to RMB 117.7 million as of June 30, 2020, representing a reduction of approximately 66.6%[96]. - The company’s related party payables to Zhejiang Jiahu Energy Chemical Co., Ltd. decreased from RMB 219.2 million to RMB 77.3 million, a decline of approximately 64.8%[96]. - The company’s receivables from related parties rose to RMB 583,201,000 as of June 30, 2020, compared to RMB 284,104,000 as of December 31, 2019, indicating an increase of approximately 105.5%[93].